Who is sponsoring NCT00509639?

NCT00509639 is sponsored by S.L.A. Pharma AG.

What condition does NCT00509639 study?

NCT00509639 studies Crohn's Disease.

What drugs are being tested in NCT00509639?

Interventions: 10% Metronidazole Ointment.

What is the status of NCT00509639?

NCT00509639 is currently COMPLETED.

Last reviewed 2012-12-12 · How we verify

Phase III Study to Evaluate the Effect of 10% Metronidazole Ointment, Applied Topically Three Times a Day in and Around the Anus and the Change in Perianal Crohn's Disease Activity

NCT00509639 Phase 3 COMPLETED

The purpose of this study is to compare changes in Perianal Crohn's Disease following use of locally applied 10% metronidazole ointment and a placebo.

Details

Lead sponsor	S.L.A. Pharma AG
Phase	Phase 3
Status	COMPLETED
Enrolment	74
Start date	2005-05
Completion	2008-02

Conditions

Crohn's Disease

Interventions

10% Metronidazole Ointment

Primary outcomes

To evaluate the effect of 10% metronidazole ointment, applied topically three times a day, in and around the anus, on the change in perianal Crohn's disease activity. — Four weeks
Perianal Crohn's Disease Activity Index

Countries

United States, United Kingdom